CCS
RCPI

Crosspoint Capital Strategies’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Crosspoint Capital Strategies’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,580
Closed -$6K – 1350
2015
Q3 		$6K Buy
+7,580
New +$8.44K 0.01% 491

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Crosspoint Capital Strategies's RCPI Position: Q4 2015 in Review

Crosspoint Capital Strategies sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 7,580 shares — an estimated $6K sold.

Crosspoint Capital Strategies first reported a position in RCPI in Q3 2015 and held it in 1 quarter. The position peaked at $6K in Q3 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Crosspoint Capital Strategies reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 7,580 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $6K.
  • Crosspoint Capital Strategies first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q3 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $6K in Q3 2015.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2015, filed 16 Feb 2016.